Prospect Financial Services LLC Acurx Pharmaceuticals, Inc. Transaction History
Prospect Financial Services LLC
- $121 Billion
- Q1 2024
A detailed history of Prospect Financial Services LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Prospect Financial Services LLC holds 272,850 shares of ACXP stock, worth $589,356. This represents 0.55% of its overall portfolio holdings.
Number of Shares
272,850
Previous 255,150
6.94%
Holding current value
$589,356
Previous $977 Million
31.59%
% of portfolio
0.55%
Previous 0.99%
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.25MCall Options Held
16.1KPut Options Held
33.8K-
Vanguard Group Inc Valley Forge, PA492KShares$1.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA116KShares$251,3200.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ57.3KShares$123,6600.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$93,8860.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC40.2KShares$86,9070.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $25M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...